CIDRAP newsletters options
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Today the World Health Organization (WHO) updated its Q and A document that covers developments surrounding Dengvaxia, Sanofi's dengue vaccine. It says its Strategic Advisory Groups of Experts (SAGE) will undertake a full rigorous view of new data to update its position paper on the vaccine, which won't likely be available until after April 2018.
The USDA proposes moving away from a per-bird payment for outbreak response efforts.
Broad-spectrum antibiotics didn't produce better clinical or patient-centered results.
The Saudi Arabian Ministry of Health (MOH) announced a new case of MERS-CoV in Taif today.
A 45-year-old Saudi woman is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. Her source of infection is listed as "primary," meaning it's unlikely she contracted the virus from another person. She is not a healthcare worker.
The FDA bans the marketing of OTC antiseptics containing triclosan and 23 other active antimicrobial agents.
A study yesterday in Clinical Infectious Diseases reports high long-term success rates of fecal microbiota transplant (FMT) against recurrent Clostridium difficile infection (CDI).
Emory University researchers contacted all eligible patients who received FMT for recurrent CDI from Jul 1, 2012, to Dec 31, 2016. Of 190 eligible patients, 137 (72%) completed the telephone survey.
The World Health Organization (WHO), in an update yesterday on 18 Saudi MERS-CoV cases, said that 5 of the 18 cases involved contact with camels before symptom onset.
Only 19 states reported increasing or maintaining their public health budgets, down from 26 last year.
Researchers are relieved to resume experiments, but some public health questions remain.
According to an updated situation report from the Nigeria Centre for Disease Control (NCDC), there are now 61 monkeypox cases in that country, 5 more than last month. This is Africa's largest-ever monkeypox outbreak.
A phase 3 trial shows ceftazidime-avibactam "non-inferior" to meropenem.
"Censorship . . . threatens to disrupt a prime goal of government: protecting public safety," the groups write.
According to an updated case count from the Centers for Disease Control and Prevention (CDC), there are now 174 cases of Candida auris infections in the United States, 17 more than the CDC reported last month.
President Donald Trump today released a new foreign strategy called the "America First" document, outlining his administration's geopolitical goals. In addition to naming Russia and China as America's "rivals," the president dedicates less than 1 page of the 68-page document to the threats posed by biological weapons.
A 3-track system would offer key advantages to the FDA's approach, the experts say.
Flu activity is widespread in 12 states, and the CDC reports a variant H3N2 case and a flu-related death in a child.
An Escherichia coli outbreak in Canada linked to romaine lettuce now involves five provinces, with 30 cases reported so far, 1 of them fatal, the Public Health Agency of Canada (PHAC) said yesterday in an update.
The results of a large randomized trial show that adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with Staphylococcus aureus bacteremia, UK researchers reported yesterday in The Lancet.
